Medical News

RSS

SBi's Mini-Rail System and Cannulated Screw System receive FDA pre-market clearance

Small Bone Innovations, Inc. (SBi), a leading, privately-held orthopedics company focused exclusively on technologies and treatments for the small bones & joints, announced that it has received 510(k) pre-market clearance notifications from the U.S. Food and Drug Administration (FDA) for Mini-Rail Fixation System (‘Mini-Rail System’) and large Cannulated Screw System for use in lower limb reconstruction and repair procedures.

25 Feb 2010

Researchers develop evaluation tool to help guide asymptomatic pancreatic cyst treatment

As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient's lifetime.

25 Feb 2010

Obama, GOP clash over summit starting point; Voters note partisan divide

The Obama administration says its health overhaul proposal is a starting point, not a final word, Reuters reports. "It is important to understand that this proposal isn't meant to be the final say on the legislation,' Nancy-Ann DeParle, director of the White House Office of Health Reform, said in an email."

25 Feb 2010

Special Issue of Business Horizons addresses issues central to healthcare and life sciences

A recent Special Issue of Business Horizons (www.elsevier.com/locate/bushor), the journal of the Kelley School of Business, Indiana University, and published by Elsevier, addresses issues central to healthcare and life sciences. Healthcare reform, for example, has been at the center of U.S. political debate in recent years with renewed attempts to gain bipartisan support from Congress for passage of a national system of health insurance coverage.

25 Feb 2010

Current health reform debate haunted by health bills of the past

Key provisions of the 1993 Republican bill, introduced by Sen. John Chafee, R-R.I., with 19 other Republicans and two Democrats, "may seem familiar, as they bear a strong resemblance to those in the current Democratic Senate bill, and now in President Barack Obama's proposal," Kaiser Health News reports. "A mandate that individuals buy insurance, subsidies for the poor to buy insurance and the requirement that insurers offer a standard benefits package and refrain from discriminating based on pre-existing conditions were all in the 1993 GOP bill."

25 Feb 2010

Anadys Pharmaceuticals' ANA598 combination demonstrates 73% cEVR in ongoing Phase II study for HCV

Anadys Pharmaceuticals, Inc. today announced preliminary results from an ongoing Phase II study demonstrating that 73% of hepatitis C patients treated with 200 mg ANA598 twice daily in combination with pegylated interferon and ribavirin (SOC) achieved undetectable levels of virus (<15 IU/mL) at week 12, known as complete Early Virological Response or cEVR.

25 Feb 2010

Study examines range of health issues and trends among older women in California

Older women who are divorced, separated or widowed or who have never married have twice the uninsured rate of their married peers, according to a new policy brief from the UCLA Center for Health Policy Research.

25 Feb 2010

MedNet Solutions introduces iMedNet eClinical technology platform

MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce iMedNet™, the company's ground-breaking new electronic data capture (EDC)/eClinical technology platform.

24 Feb 2010

The Democrats' 2010 health reform plan evokes 1993 Republican bill

Kaiser Health News Maggie Mertens spoke to former Sen. Dave Durenberger, R-Minn., about his take on past and present health reform politics. In 1993, at the height of President Bill Clinton's health care reform initiative, Sen. John Chafee, R-R.I., along with 19 other Republicans and two Democrats, put forth a bill which was considered the major GOP proposal.

24 Feb 2010

Welichem commences enrollment in WBI-1001 Phase IIa clinical trial for psoriasis

Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.

24 Feb 2010

Minimally Invasive Thoracic Surgery program performed at John Muir Medical Center

As part of John Muir Health’s Minimally Invasive Thoracic Surgery program, a minimally invasive thymectomy – removal of the thymus gland – was successfully performed recently at the John Muir Medical Center – Concord Campus. This procedure, designed to minimize trauma to patients, uses the latest generation da Vinci® Si Surgical System to help surgeons see vital anatomical structures more clearly and to perform a more precise operation.

24 Feb 2010

House to vote on ending insurer antitrust exemption today, White House backs measure

The Obama administration is supporting a House bill that would end the federal antitrust exemption for health insurers.

24 Feb 2010

Democrats revisit reconciliation as means to pass overhaul

Reconciliation, a parliamentary tactic that could allow Congress to pass health reform with a simple Senate majority, was dismissed weeks ago by centrist Democrats, but some of those lawmakers are now warming to the approach, clearing a possible avenue for passage of the overhaul, Politico reports. "Obviously, if the minority is just frustrating the process, that argues for taking steps to get the public's business done," said Sen. Evan Bayh, D-Ind., one of the senators to reverse course on reconciliation (Budoff Brown, 2/23).

24 Feb 2010

Researchers to test Radio-embolisation technique in patients with bowel cancer

Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy.

24 Feb 2010

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon’s PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

24 Feb 2010

Anthem Blue Cross will go forward with rate hikes, execs tell Calif. lawmakers

Anthem Blue Cross executives told California lawmakers Tuesday that they plan to go ahead with a rate hike of up to 39 percent for individual health insurance policies.

24 Feb 2010

Abortion, public option questions remain

The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.

24 Feb 2010

Unique technology identifies drug candidates, speeds up drug development

The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate.

From NanoTemper Technologies 24 Feb 2010

American People's Online Health Summit to be hosted in response to bipartisan health summit

In response to President Barack Obama's bipartisan health summit on February 25, Newt Gingrich's Center for Health Transformation will host the "American People's Online Health Summit," a LIVE blog to engage the American people in health reform negotiations and give them a voice in Washington.

24 Feb 2010

Novelos Therapeutics' NOV-002 Phase 3 NSCLC trial fails to meet primary survival endpoint

Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the primary endpoint of improvement in overall survival was not met in Novelos’ pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy. Detailed trial results are expected to be presented via appropriate scientific venue later this year.

24 Feb 2010

Medical News

SBi's Mini-Rail System and Cannulated Screw System receive FDA pre-market clearance

Researchers develop evaluation tool to help guide asymptomatic pancreatic cyst treatment

Obama, GOP clash over summit starting point; Voters note partisan divide

Special Issue of Business Horizons addresses issues central to healthcare and life sciences

Current health reform debate haunted by health bills of the past

Anadys Pharmaceuticals' ANA598 combination demonstrates 73% cEVR in ongoing Phase II study for HCV

Study examines range of health issues and trends among older women in California

MedNet Solutions introduces iMedNet eClinical technology platform

The Democrats' 2010 health reform plan evokes 1993 Republican bill

Welichem commences enrollment in WBI-1001 Phase IIa clinical trial for psoriasis

Minimally Invasive Thoracic Surgery program performed at John Muir Medical Center

House to vote on ending insurer antitrust exemption today, White House backs measure

Democrats revisit reconciliation as means to pass overhaul

Researchers to test Radio-embolisation technique in patients with bowel cancer

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Anthem Blue Cross will go forward with rate hikes, execs tell Calif. lawmakers

Abortion, public option questions remain

Unique technology identifies drug candidates, speeds up drug development

American People's Online Health Summit to be hosted in response to bipartisan health summit

Novelos Therapeutics' NOV-002 Phase 3 NSCLC trial fails to meet primary survival endpoint

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News